Biotech Scan

Scan

Biotech Scan

raw scan snapshot — prices as of scan date, not live 26 rows · screens, not recommendations ported fromresearch/classic/scans/2026-04-10-biotech-scan.md

Large-cap pharma holding steady while NVO collapses (-54% from high); MRNA a surprise strong-up on 54% 3M rally; gene editing mixed.

Quick Snapshot

Signal Reading
Overall 🟡 Mixed — pharma stable, Novo Nordisk in freefall, MRNA rebounding
Key insight NVO -54% from high (obesity drug competition fears); MRNA +54% 3M comeback; VEEV extreme oversold at RSI 22

Price Table

Stock Price RSI vs SMA20 7D% 30D% 3M% Trend Signal
ABBV $210.23 44.1 -0.4% +2.06% -7.39% -3.69% down 🔍 Watch
GILD $140.70 50.0 +0.6% +1.23% -4.75% +15.41% weak-down 🔒 Hold
AMGN $352.56 48.0 +0.2% +2.39% -6.09% +9.05% weak-down 🔒 Hold
REGN $748.15 45.6 -0.7% +0.30% -3.09% -2.47% weak-down 🔒 Hold
BIIB $173.72 39.9 -4.5% +0.37% -7.80% -6.42% weak-down 🔍 Watch
LLY $939.32 47.3 +1.3% +2.49% -6.19% -12.96% weak-down 🔍 Watch
VRTX $437.06 42.0 -2.6% +1.83% -12.44% -5.11% down 🔍 Watch
NVO $37.51 48.6 +3.4% +1.03% +0.43% -35.04% strong-down 🔍 Research
BNTX $93.39 51.2 +4.0% +0.79% +11.32% -8.60% strong-down 🔍 Watch
MRNA $52.23 54.6 +1.6% +3.64% -5.00% +54.34% strong-up 🔒 Hold
ALNY $324.77 50.7 +1.5% -3.49% +0.74% -12.44% strong-down 🔍 Watch
BMRN $54.72 41.3 -1.9% +0.12% -10.13% -5.18% down 🔍 Watch
INCY $95.99 52.7 +3.0% +1.52% -0.03% -9.72% weak-down 🔍 Watch
CRSP $50.17 50.3 +4.0% +3.54% -4.98% -9.28% strong-down 🔍 Watch
BEAM $26.35 55.1 +7.3% +6.25% +1.04% -21.79% strong-up 🔍 Watch
EDIT $2.81 65.5 +12.6% up ⚠️ Speculative
GRDN $39.38 63.5 +7.5% +3.78% +17.03% +24.98% strong-up 🔒 Hold

Entry Zones

Stock Price RSI 30D% Setup
NVO $37.51 48.6 +0.43% Bouncing from -54% high, still in death cross — wait for trend change
BIIB $173.72 39.9 -7.80% Approaching oversold, -14% from high
BMRN $54.72 41.3 -10.13% Rare disease franchise getting cheap

Action Matrix

Action Stocks Why
🔒 HOLD GILD, AMGN, REGN, MRNA, GRDN Stable trends, thesis intact
🔍 WATCH LLY, ABBV, VRTX, ALNY Pulling back but quality names
🔍 RESEARCH NVO Obesity drug thesis in question — deep value or value trap?
⚠️ AVOID EDIT Micro-cap speculative, no revenue
10 events

No direct external sources are attached to this read.